NCT01640769

Brief Summary

This randomized controlled trial will assess a cardiac MRI derived 4D digital cardiac model to optimized left and right ventricular lead delivery to improve response to cardiac resynchronization therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 16, 2012

Completed
2.1 years until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
7.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

June 25, 2025

Status Verified

June 1, 2025

Enrollment Period

7.3 years

First QC Date

July 9, 2012

Last Update Submit

June 18, 2025

Conditions

Keywords

CardiomyopathyCardiac Resynchronization TherapyImage guided therapyDigital twinsCardiac Magnetic Resonance ImagingMRI

Outcome Measures

Primary Outcomes (1)

  • Determination of response to image guided placement of cardiac ventricular pacing leads in cardiac resynchronization therapy (CRT)

    Cardiac Resynchronization Therapy (CRT) response will be defined as a change in the Left Ventricular Ejection Fraction measured at 6 months post CRT device implant by MUGA (multigated acquisition scan / wall motion study).

    6 months

Secondary Outcomes (10)

  • All-cause mortality

    12 months

  • Heart failure hospital admissions

    12 months

  • improvement in 6-minute hall walk ≥ 30 meters or ≥ 10%

    6 months

  • Improvement in New York Heart Association (NYHA) functional class by ≥ 1

    6 months

  • Improvement in Quality of Life (QOL) score by ≥ 10 points

    6 months

  • +5 more secondary outcomes

Study Arms (2)

Image guided delivery of pacing leads

ACTIVE COMPARATOR

4D model-guided placement of LV and RV leads to optimal myocardial targets, as derived from pre-procedural Cardiac MRI

Procedure: 4D Model guided delivery of cardiac pacing leads

Standard delivery of pacing leads

PLACEBO COMPARATOR

Standard LV and RV lead placement

Procedure: Standard CRT lead delivery

Interventions

4D model-guided placement of LV and RV leads to optimal myocardial targets, as derived from pre-procedural Cardiac MRI

Image guided delivery of pacing leads

Standard lead delivery

Standard delivery of pacing leads

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years.
  • Ejection fraction ≤ 35 %.
  • LBBB with QRS duration ≥ 120 msec.
  • NYHA class II-IV.
  • On maximum tolerated heart failure medication therapy ≥ 6 weeks.
  • Clinically accepted for CRT device implantation.

You may not qualify if:

  • Failure to provide consent.
  • CCS class III-IV angina.
  • Recent Q-wave myocardial infarction or revascularization procedure ( ≤ 3 months).
  • Atrial fibrillation at time of randomization \>6 weeks in duration
  • Standard contra-indications to MRI.
  • Documented severe allergy to intravenous contrast dye ( iodinated CT contrast or Gadolinium MRI contrast).
  • Estimated Glomerular Filtration Rate (eGFR) ≤ 45 ml/min/m2.
  • Patient is pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Conect Research, University of Calgary

Calgary, Alberta, T2N 4Z6, Canada

Location

Halifax Capital Districy Health Authority

Halifax, Nova Scotia, B3H3A7, Canada

Location

Libin Cardiovascular Institute

London, Ontario, N6A5A5, Canada

Location

Ottawa Heart Institute Research Corporation

Ottawa, Ontario, K1Y4W7, Canada

Location

University of Laval Research Centre

Québec, Quebec, G1V 4G5, Canada

Location

Related Publications (2)

  • Chew DS, Vandenberk B, Exner DV, Labib D, Flewitt J, Mikami Y, Rivest S, Chan D, Manlucu J, Leong-Sit P, Rinne C, Birnie DH, Nery P, Sumner G, Ayala-Paredes F, Philippon F, Yee R, White JA. 4D Digital Heart Model-Guided Left and Right Ventricular Lead Placement for Cardiac Resynchronization Therapy: Results of MAPIT-CRT Trial. Circ Arrhythm Electrophysiol. 2025 Dec 25:e014132. doi: 10.1161/CIRCEP.125.014132. Online ahead of print.

  • Laksman Z, Yee R, Stirrat J, Gula LJ, Skanes AC, Leong-Sit P, Manlucu J, McCarty D, Turkistani Y, Scholl D, Rajchl M, Goela A, Islam A, Thompson RT, Drangova M, White JA. Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study. Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1040-7. doi: 10.1161/CIRCEP.114.001729. Epub 2014 Sep 14.

MeSH Terms

Conditions

Heart Failure, SystolicCardiomyopathies

Condition Hierarchy (Ancestors)

Heart FailureHeart DiseasesCardiovascular Diseases

Study Officials

  • James White, MD

    University of Calgary

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 4 dimensional cardiac model to guide optimal delivery of left and right ventricular pacing leads in patients referred for cardiac resynchronization therapy.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 9, 2012

First Posted

July 16, 2012

Study Start

September 1, 2014

Primary Completion

January 1, 2022

Study Completion

January 1, 2023

Last Updated

June 25, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations